PRINTO (the Paediatric Rheumatology International Trials Organisation)
NCT00415935 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2006-12-25
Summary
A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months
Conditions
- Juvenile Idiopathic Arthritis
Interventions
- DRUG
-
methotrexate
Sponsors & Collaborators
-
Institute of Child Health
lead OTHER
Principal Investigators
-
Lucy Wedderburn, Dr · Institute Of Child Health and Great Ormond Street Hospital
Eligibility
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2006-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
NCT01015547 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)
NCT01844518 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
NCT05814159 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)
NCT00642460 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur
NCT03769558 ·Status: COMPLETED
-
A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis
NCT00988221 ·Status: COMPLETED ·Phase: PHASE3
-
Pediatric Arthritis Study of Certolizumab Pegol
NCT01550003 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults
NCT00534495 ·Status: COMPLETED ·Phase: PHASE2
-
Juvenile Idiopathic Arthritis (JIA) Registry
NCT00783510 ·Status: COMPLETED
-
Start Time Optimization of Biologics in Polyarticular JIA
NCT02593006 ·Status: COMPLETED
-
A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)
NCT01455701 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)
NCT00144612 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis
NCT01142726 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA
NCT03000439 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
NCT01904292 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX
NCT03975790 ·Status: COMPLETED
-
A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA)
NCT01904279 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis
NCT00036374 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients
NCT01001832 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Articular Damage in Patients With Juvenile Idiopathic Arthritis After Transition to Adult Care
NCT06895278 ·Status: NOT_YET_RECRUITING
-
Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
NCT00426218 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis
NCT00868751 ·Status: TERMINATED ·Phase: NA
-
Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)
NCT01481493 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)
NCT00048542 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings
NCT02758769 ·Status: COMPLETED